Latest Cash Flow And Funding News

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

Judo Bank has reported a robust half-year performance with a 70% jump in statutory net profit, driven by strong loan growth and improved margins, while reaffirming its FY25 profit guidance.

Vulcan Steel Limited reported a challenging first half of FY25 with significant declines in revenue, EBITDA, and net profit, yet maintained a solid 10% return on capital employed and declared a cautious interim dividend.

Aeris Environmental has updated its quarterly cash flow report, confirming ongoing operational cash outflows but expressing confidence in maintaining current cash flow levels while exploring new funding avenues.

Catalyst Metals Limited is ramping up exploration in the historically underexplored Plutonic Gold Belt, aiming to boost annual gold production from 110,000 to 200,000 ounces. With a robust cash position and a $40 million drilling program underway, the company is poised to unlock significant new resources.

Culpeo Minerals Limited reported a net cash outflow of $246,000 for the December 2024 quarter but retains robust liquidity with $3.7 million in available funding. The company’s cash position and financing facilities suggest it is well-positioned to continue its exploration activities.

DTI Group Limited has inked a global Master Framework Agreement with Siemens Mobility GmbH, streamlining worldwide purchasing and opening doors to new rail and bus sector projects. Despite a modest cash balance, DTI is advancing its flagship software, positioning itself for growth.

Excite Technology Services has achieved positive EBITDA in December 2024, driven by strong revenue growth and record customer receipts, notably from its Digital Forensics division and the integration of CDFS.

A1 Investments & Resources Ltd reports a modest cash outflow for the June 2024 quarter while actively pursuing acquisitions and planning convertible note funding to support growth.

Riedel Resources has increased its ownership in the Kingman Project to 90%, completed a key cultural survey, and is actively exploring toll treatment options and new projects to expand its portfolio.

Argenica Therapeutics has dosed 80% of patients in its Phase 2 stroke trial and gained FDA orphan drug designations for its second candidate, ARG-006. The company reports a cash-positive quarter with $15 million in reserves.

Dreadnought Resources has strategically acquired tenement E09/2383, consolidating its Mangaroon Gold Project and unlocking access to high-grade gold mineralisation at the Jailor target. This move sets the stage for intensified exploration activities starting February 2025.